GLP 1 Agonists: Therapies for type II diabetes, obesity, and addiction(?)


Episode Artwork
1.0x
0% played 00:00 00:00
Feb 07 2024 43 mins  

Thanks for reading Neural Pharm! Subscribe for free to receive new posts and support my work.

References:

Arrone L, et al. Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: the SURMOUNT-4 Randomized Clinical Trial. JAMA. 11 Dec 2023. https://jamanetwork.com/journals/jama/fullarticle/2812936

Attia P and Gifford B. Outlive: The Science & Art of Longevity First edition., Harmony, 2023.

Bliss M. The History of a Wonderful Thing We Call Insulin. American Diabetes Association. 1 July 2019. https://diabetes.org/blog/history-wonderful-thing-we-call-insulin

Hendershot C. Use of GLP-1 Receptor Agonists to Treat Substance and Alcohol Use. University of North Carolina. 5 Dec 2023. https://news.unchealthcare.org/2023/12/use-of-glp-1-receptor-agonists-to-treat-substance-and-alcohol-use-disorders-is-promising-but-premature/.

Jay M. Walmart says users of weight loss drug are buying less food. NBC News. 5 Nov 2023. https://www.nbcnews.com/business/consumer/ozempic-drug-users-are-buying-less-food-walmart-says-rcna119000

Klausen M, et al. The Role of Glucagon Like 1 Peptide (GLP-1) in Addictive Disorders. British Journal of Pharmacology. Feb. 2022. https://pubmed.ncbi.nlm.nih.gov/34532853/

Leslie M. Hot Weight Loss Drugs Tested Against Addiction. Science. Sept 2023. https://www.science.org/content/article/hot-weight-loss-drugs-tested-addiction-treatments

Lingvay I, et al. Efficacy and Safety of Once Weekly Semaglutide versus daily Canagliflozin as add-on to Metformin in Patients with Type 2 Diabetes (SUSTAIN 8)…The Lancet. Nov 2019. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30311-0/fulltext

Mansour N, et al. Effects of Early Adjunctive Pharmacotherapy on Serum Levels of Brain Injury Biomarkers in Patients with Traumatic Brain Injury: A Systematic Review of Randomized Controlled Studies. Frontiers in Pharmacology. 4 May 2023. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1185277/full

Mckenzie H. GLP-1 Drugs Show Promise in Alcohol, Opioid Use Disorders. Biospace. 3 Aug 2023. https://www.biospace.com/article/glp-1-drugs-show-promise-in-alcohol-opioid-use-disorders-/.

Quianzon C, et al. History of Current Non-Insulin Medications for Diabetes Mellitus. Journal of Community Hospital: Internal Medicine Perspectives. 15 Oct 2012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714066/

Reger M, et al. Tramautic Brain Injury and Veteran Mortality After the War in Afghanistan. JAMA. 11 Feb 2022. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788981#:~:text=Estimates%20suggest%20that%20between%209,service%20members%20experienced%20a%20TBI.&text=Complicating%20matters%20further%2C%20many%20veterans,the%20worst%20lifetime%20injury%20sustained

Shevchouck O, at al. An Overview of Appetite-Regulatory Peptides in Addiction Processes: From Bench to Bed Side. Frontiers in Neuroscience. 8 Dec 2021. https://www.frontiersin.org/articles/10.3389/fnins.2021.774050/ful



Get full access to Neural Pharm at neuralpharm.substack.com/subscribe